Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
Title: Editorial [ A Novel Immunobiological Drugs in Dermatology Guest Editor: Neslihan ??endur ]
Volume: 6 Issue: 3
Author(s): Neslihan Sendur
Affiliation:
Export Options
About this article
Cite this article as:
Neslihan Sendur , Editorial [ A Novel Immunobiological Drugs in Dermatology Guest Editor: Neslihan ??endur ], Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry 2007; 6 (3) . https://dx.doi.org/10.2174/187152307781368274
DOI https://dx.doi.org/10.2174/187152307781368274 |
Print ISSN 1871-5230 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-614X |
16
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Oral Antidiabetic Agents: Anti-Atherosclerotic Properties Beyond Glucose Lowering?
Current Pharmaceutical Design Disease-Modifying Effect of Anthraquinone Prodrug with Boswellic Acid on Collagenase-Induced Osteoarthritis in Wistar Rats
Inflammation & Allergy - Drug Targets (Discontinued) Molecular and Cellular Mechanism of Cutaneous Injuries Due to Exposure to Sulfur Mustard
Letters in Drug Design & Discovery Leptin as a Novel Therapeutic Target for Immune Intervention
Current Drug Targets - Inflammation & Allergy Acute Inflammation and Oxidative Stress Induced by Lipopolysaccharide and the Ameliorative Effect of Stingless Bee Honey
Combinatorial Chemistry & High Throughput Screening Endothelial Dysfunction and the Effects of TNF Inhibitors on the Endothelium in Psoriasis and Psoriatic Arthritis: A Systematic Review
Current Pharmaceutical Design Physiologic Versus Diabetogenic Effects of Interleukin-1: A Question of Weight
Current Pharmaceutical Design Inflammatory Biomarkers for Mood Disorders - A Brief Narrative Review
Current Pharmaceutical Design Preface [Hot Topic: Antimycobacterial Drugs: Current Status and Future Prospects (Executive Editor: Haruaki Tomioka)]
Current Pharmaceutical Design Cytoprotective Strategy Against Pulmonary Fibrosis
Drug Design Reviews - Online (Discontinued) Ryanodine Receptor Patents
Recent Patents on Biotechnology Interactions of Ginkgolides A and B with a Recombinant Human Prion Protein
Protein & Peptide Letters IL-13: A Promising Therapeutic Target for Bronchial Asthma
Current Medicinal Chemistry Application of SCR Priming VLP Boosting as a Novel Vaccination Strategy Against HIV-1
Current HIV Research Can Lipoprotein-associated Phospholipase A<sub>2</sub> be Used as a Predictor of Long-term Outcome in Patients with Acute Coronary Syndrome?
Current Cardiology Reviews Focused Microarray Analysis: Characterization of Phenomes by Gene Expression Profiling
Current Pharmacogenomics A Review of the Immunosuppressive Activity of Cyclosporine Metabolites:New Insights into an Old Issue
Current Clinical Pharmacology Effect of <i>Umbelliprenin</i> on Antinociceptive Activity of Morphine in a Rat Model of Neuropathic Pain Induced by Chronic Constriction Injury of the Sciatic Nerve
The Natural Products Journal Disorders of Mechanisms of Calcium Metabolism Control as Potential Risk Factors of Prostate Cancer
Current Medicinal Chemistry Neuroprotective Methodologies of Co-Enzyme Q10 Mediated Brain Hemorrhagic Treatment: Clinical and Pre-Clinical Findings
CNS & Neurological Disorders - Drug Targets